Here you go: The New England Journal of Medicine (NEJM)

New Post Public Reply Private Reply Replies (1) Message Board
ClosetInvestor HCIT #26208
905
Here you go:

The New England Journal of Medicine (NEJM) is the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed research and interactive clinical content to physicians, educators, and the global medical community.

Our mission is to bring physicians the best research and information at the intersection of biomedical science and clinical practice and to present this information in understandable and clinically useful formats that inform health care delivery and improve patient outcomes.
To these ends, the NEJM editorial team employs rigorous:

Editorial, peer, and statistical review processes to evaluate manuscripts for scientific accuracy, novelty, and importance.

Policies and practices to ensure that authors disclose all relevant financial associations and that such associations in no way influence the content NEJM publishes.

A truly global brand, NEJM keeps health care professionals at the leading edge of medical knowledge, helps them to gain broad understanding in their areas of interest, and provides valuable perspectives on the practice of medicine.

NEJM History
John Collins Warren, a Boston physician and scholar, collaborated in 1811 with colleague James Jackson to establish the first medical journal in New England, publishing the first quarterly edition of the New England Journal of Medicine and Surgery and the Collateral Branches of Medical Science (Boston) in January of 1812.

In 1921, the journal merged with the Boston Medical Intelligencer to become the Boston Medical and Surgical Journal; it also began weekly publication that year and was purchased by the Massachusetts Medical Society.
Renamed to the New England Journal of Medicine in 1928, the journal is known for many firsts in medicine, including the first to publish a full description of spinal disk rupture (1934), the first to document success in treating early childhood leukemia (1948), and the first American medical journal to receive the Polk Award for journalistic excellence. For additional NEJM historical milestones, see Fact Sheet.

NEJM Today
Today, NEJM is the most widely read, cited, and influential general medical periodical in the world. More than 600,000 people from nearly every country read NEJM in print and online each week.
Each year, NEJM receives more than 16,000 research and other submissions for consideration for publication. About 5% of original research submissions achieve publication by NEJM; more than half originate from outside the U.S.

NEJM is cited more often in scientific literature than any other medical journal, and has the highest Journal Impact Factor (70.670) of all general medical journals (2018 Journal Citation Reports, Web of Science Group, 2019).

NEJM is a Public Access Journal. All original research content is freely available on NEJM.org six months after the date of publication. In addition, qualifying low-income countries are granted free access to all articles on NEJM.org dating back to 1990. The editors may also make certain materials including articles on global health and of public health importance free to all readers immediately upon publication on NEJM.org

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 2

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Alex Jones Returns to Austin: New Studio, New Plans

Updated Category News Views 3

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Continue Reading
Catalina Behavioral Health: 4 Years, 1,000 Lives Touched

Updated Category News Views 3

Pioneering Care in Behavioral Health Catalina Behavioral Health is proving that four years can make a difference. From their base in Tucson, they've grown to serve 1,000 souls navigating the stormy waters of addiction and mental health. It's not just about numbers, you see—this milestone marks real lives changed, one battle at a time. Building Trust, One Patient at a...

Continue Reading
VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Updated Category News Views 4

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Continue Reading
Newmark's $482.5M Loan Fuels Steamboat Resort Expansion

Updated Category News Views 4

Newmark Banks on Steamboat's Future Diving headfirst into the deep end, Newmark (NASDAQ: NMRK) just roped in a colossal $482.5 million loan for a new gem in Steamboat Springs, Colorado. Inking a deal of this magnitude ain't your everyday rinse-and-repeat; it's a bold move that speaks volumes about where the big shots think value's heading. The Financial Fuel: GoldenTree...

Continue Reading
Miguel Pantoja: Wiring a Second Chance Beyond Bars

Updated Category News Views 3

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 5

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading
Mattamy Homes Earns Spot as Top Workplace in Jacksonville

Updated Category News Views 8

Jacksonville's Housing Scene Gets a Boost In a world where everyone seems bent on working down to the bone to climb some imaginary corporate ladder, here comes Jacksonville's own Mattamy Homes with a news flash—it's possible to work, live, and still smile at the end of the day. Recently, they earned themselves a coveted spot among the best workplaces in Jacksonville for...

Continue Reading
AMD CEO, Global Leaders Converge At IMPERIA Summit

Updated Category News Views 3

A Clash of Giants in New York The trade floors are buzzing in New York as the world's economic heavyweights and tech titans gather for the inaugural IMPERIA Summit. You can almost smell the pressure and ambition wafting through the streets when folks like AMD's CEO, Lisa Su, share the stage with geopolitical power players like President Trump and China's President Xi...

Continue Reading
Decision Logic Innovates with Vitals & ShiftFlow Tools

Updated Category News Views 4

Restaurant Battlefields: The Need for Real-Time Response Running a restaurant is no walk in the park. One slip, and you're dealing with spoiled soup or crabby customers. Decision Logic reckons they've cracked the code to smoother operations with their new tools, Vitals and ShiftFlow. At heart, these products do one thing: put critical data into the hands of managers while...

Continue Reading

Top 5 Most Recently Viewed Articles

Will Smith Shines at Middle East Premiere of Unique Series

Updated Category News Views 136

Will Smith Shines at Middle East Premiere of Unique Series Will Smith, a global entertainment icon, captivated audiences at the much-anticipated Middle East premiere of Pole to Pole with Will Smith. This significant event was held at the SEE Institute, recognized as the region's first net-zero emissions building located within The Sustainable City. The gathering united a...

Continue Reading
Voyager Technologies Takes Steps Towards IPO with SEC Filing

Updated Category News Views 752

Voyager Technologies Pursues Initial Public Offering In a significant move, Voyager Technologies has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission (SEC). This step is crucial for the company as it aims to initiate a public offering of its common stock. While details regarding the number of shares or the...

Continue Reading
Dot Inc. and WEBTOON Bring Comics to Life for All Readers

Updated Category News Views 243

Innovative Partnership Expands Comic Accessibility In a groundbreaking collaboration, WEBTOON Entertainment and Dot Inc. have joined forces to innovate how visually impaired audiences can access popular webcomics. This partnership aims to turn beloved WEBTOON titles like "Yumi's Cells" and "Hooky" into tactile digital formats that can be read in braille on the Dot Pad, a...

Continue Reading
Orsini Partners with Crinetics for Innovative Acromegaly Treatment

Updated Category News Views 253

Orsini's Role in Acromegaly Treatment Orsini has been selected as the specialty pharmacy partner for Crinetics Pharmaceuticals, Inc., to provide PALSONIFY™ (paltusotine), a groundbreaking therapy for treating acromegaly. This new oral therapy is designed for adults who either did not respond adequately to surgery or for whom surgical intervention is not viable. The...

Continue Reading
Investors Can Join Class Action in DeFi Technologies Case

Updated Category News Views 98

Investors Encouraged to Step Forward for DeFi Technologies Case In light of significant developments regarding DeFi Technologies Inc. (NASDAQ: DEFT), a call to action has emerged for investors affected by misleading information related to the company's performance. With a class action lawsuit now filed, those who purchased securities of the company during the specified...

Continue Reading